FivePrime Therapeutics Articles

Human Genome Sciences inks up to $495 million deal with FivePrime for cancer drug

17 March 2011

GlaxoSmithKline buys rights to muscle disorder drugs from FivePrime, in deal worth up to $139 million; Merck KGaA reportedly looking to sell infertility franchise

4 August 2010

Showing 1-2 of 2 articles

Go to beginningPrevious
  • 1
NextGo to end